DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00913250 (ClinicalTrials.gov)	August 2003	2/6/2009	A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers	A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of AVONEX® (Interferon Beta-1a) Solutions for Injection Produced by a Serum-Containing Manufacturing Process and by a Serum-Free Manufacturing Process	Multiple Sclerosis	Drug: Serum containing Avonex;Drug: Serum Free Avonex	Biogen Idec	NULL	Completed	18 Years	45 Years	Both	96	Phase 1	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00913250
(ClinicalTrials.gov)

August 2003

2/6/2009

A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers

A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of AVONEX® (Interferon Beta-1a) Solutions for Injection Produced by a Serum-Containing Manufacturing Process and by a Serum-Free Manufacturing Process

Multiple Sclerosis

Drug: Serum containing Avonex;Drug: Serum Free Avonex

Biogen Idec

NULL

Completed

18 Years

45 Years

Both

Phase 1

NULL